SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Five Prime Therapeutics Q1 EPS $(0.570) Beats $(0.670) Estimate

Five Prime Therapeutics (NASDAQ:FPRX) reported quarterly losses of $(0.570) per share which beat the analyst consensus estimate of $(0.670) by 14.93 percent. This is a 44.12 percent increase over losses of $(1.020) per

Benzinga · 05/07/2020 20:12

Five Prime Therapeutics (NASDAQ:FPRX) reported quarterly losses of $(0.570) per share which beat the analyst consensus estimate of $(0.670) by 14.93 percent. This is a 44.12 percent increase over losses of $(1.020) per share from the same period last year.